Julian Baker

Julian Charles Baker is the founder of Baker Bros.
Advisors LP, founded in 2000, where the title held is Managing Partner.
Current jobs include Chairman at Incyte Corp.
since 2025, Chairman at Denali Therapeutics, Inc. since 2025, Independent Chairman at Madrigal Pharmaceuticals, Inc. since 2023, Independent Director at ACADIA Pharmaceuticals, Inc. since 2015, Director at EveryONE Medicines, Inc., Managing Member at Baker Bros.
Advisors GP LLC, and Partner at FBB Associates.
Former jobs include Director at Neurogen Corp.
from 1999 to 2009, Independent Director at Idera Pharmaceuticals, Inc. from 2015 to 2018, Director at Trimeris, Inc. from 2004 to 2011, Lead Independent Director at Genomic Health, Inc. from 2012 to 2019, Director at Innoviva, Inc. from 1999 to 2007, Independent Director at Prelude Therapeutics, Inc. from 2021 to 2025, Director at Presidio Pharmaceuticals, Inc., Director at Alumis, Inc., Member at Credit Suisse First Boston Corp.
from 1988 to 1993, Principal at CSFB Private Equity Partners LLC, Advisory Board Member at Elm Street Advisors LLC, and Portfolio Manager at Tisch Financial Management from 1994 to 1999.
Education includes undergraduate degree from Harvard University.